201 related articles for article (PubMed ID: 37972709)
1. Liquid biopsy: New opportunities for precision medicine in hepatocellular carcinoma care.
Aquino IMC; Pascut D
Ann Hepatol; 2024; 29(2):101176. PubMed ID: 37972709
[TBL] [Abstract][Full Text] [Related]
2. Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma.
Lehrich BM; Zhang J; Monga SP; Dhanasekaran R
J Hepatol; 2024 Mar; 80(3):515-530. PubMed ID: 38104635
[TBL] [Abstract][Full Text] [Related]
3. Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma.
Hu M; Xia X; Chen L; Jin Y; Hu Z; Xia S; Yao X
Ann Hepatol; 2023; 28(6):101137. PubMed ID: 37451515
[TBL] [Abstract][Full Text] [Related]
4. Application of artificial intelligence radiomics in the diagnosis, treatment, and prognosis of hepatocellular carcinoma.
Bo Z; Song J; He Q; Chen B; Chen Z; Xie X; Shu D; Chen K; Wang Y; Chen G
Comput Biol Med; 2024 May; 173():108337. PubMed ID: 38547656
[TBL] [Abstract][Full Text] [Related]
5. Methylated circulating tumor DNA in hepatocellular carcinoma: A comprehensive analysis of biomarker potential and clinical implications.
Zhu Q; Xie J; Mei W; Zeng C
Cancer Treat Rev; 2024 Jul; 128():102763. PubMed ID: 38763055
[TBL] [Abstract][Full Text] [Related]
6. Methylated ctDNA Quantification: Noninvasive Approach to Monitoring Hepatocellular Carcinoma Burden.
Angeli-Pahim I; Chambers A; Duarte S; Soma D; Beduschi T; Sahin I; Hughes S; Zarrinpar A
J Am Coll Surg; 2024 Apr; 238(4):770-778. PubMed ID: 38146818
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
[TBL] [Abstract][Full Text] [Related]
8. Prospects and challenges of circulating tumor DNA in precision medicine of hepatocellular carcinoma.
Weng J; Atyah M; Zhou C; Ren N
Clin Exp Med; 2020 Aug; 20(3):329-337. PubMed ID: 32239299
[TBL] [Abstract][Full Text] [Related]
9. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
Moldogazieva NT; Zavadskiy SP; Terentiev AA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
[TBL] [Abstract][Full Text] [Related]
10. Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas.
Meriranta L; Pitkänen E; Leppä S
Semin Hematol; 2023 Jul; 60(3):132-141. PubMed ID: 37455222
[TBL] [Abstract][Full Text] [Related]
11. Current status of ctDNA in precision oncology for hepatocellular carcinoma.
Li Y; Zheng Y; Wu L; Li J; Ji J; Yu Q; Dai W; Feng J; Wu J; Guo C
J Exp Clin Cancer Res; 2021 Apr; 40(1):140. PubMed ID: 33902698
[TBL] [Abstract][Full Text] [Related]
12. Decoding the glycoproteome: a new frontier for biomarker discovery in cancer.
He K; Baniasad M; Kwon H; Caval T; Xu G; Lebrilla C; Hommes DW; Bertozzi C
J Hematol Oncol; 2024 Mar; 17(1):12. PubMed ID: 38515194
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma.
Huang X; Duijf PHG; Sriram S; Perera G; Vasani S; Kenny L; Leo P; Punyadeera C
J Biomed Sci; 2023 Aug; 30(1):65. PubMed ID: 37559138
[TBL] [Abstract][Full Text] [Related]
15. Pre-enrichment-free detection of hepatocellular carcinoma-specific ctDNA via PDMS and MEMS-based microfluidic sensor.
Çağlayan Arslan Z; Okan M; Külah H
Mikrochim Acta; 2024 Apr; 191(5):229. PubMed ID: 38565645
[TBL] [Abstract][Full Text] [Related]
16. Combining tissue and circulating tumor DNA increases the detection rate of a CTNNB1 mutation in hepatocellular carcinoma.
Oversoe SK; Clement MS; Weber B; Grønbæk H; Hamilton-Dutoit SJ; Sorensen BS; Kelsen J
BMC Cancer; 2021 Apr; 21(1):376. PubMed ID: 33827453
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy: current technology and clinical applications.
Nikanjam M; Kato S; Kurzrock R
J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
[TBL] [Abstract][Full Text] [Related]
18. Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma.
Yang JC; Hu JJ; Li YX; Luo W; Liu JZ; Ye DW
Front Oncol; 2022; 12():781820. PubMed ID: 35211399
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy for early detection of hepatocellular carcinoma.
Manea I; Iacob R; Iacob S; Cerban R; Dima S; Oniscu G; Popescu I; Gheorghe L
Front Med (Lausanne); 2023; 10():1218705. PubMed ID: 37809326
[TBL] [Abstract][Full Text] [Related]
20. Liquid Biopsy Using Cell-Free or Circulating Tumor DNA in the Management of Hepatocellular Carcinoma.
Lyu X; Tsui YM; Ho DW; Ng IO
Cell Mol Gastroenterol Hepatol; 2022; 13(6):1611-1624. PubMed ID: 35183803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
